Driuk N F, Mishalov V G, Pavlichenko L N
Klin Khir (1962). 1994(10):26-8.
Vazaprostan was prescribed to 13 patients with the lower limbs obliterating atherosclerosis and the coronary arteries atherosclerotic lesion (first group) and in 17--with obliterating atherosclerosis and endarteritis of the lower limbs vessels (second group). The treatment was found to be effective one in all of the patients of the first group and in 13--of the second. The authors consider vazaprostan application to be expedient in patients with the lower limbs obliterating lesions as a supplement to operative intervention and also in coincidence of this pathology with the ischemic heart disease.
对13例患有下肢闭塞性动脉粥样硬化和冠状动脉粥样硬化病变的患者(第一组)以及17例患有下肢血管闭塞性动脉粥样硬化和动脉内膜炎的患者(第二组)使用了瓦扎前列素。结果发现,第一组所有患者以及第二组的13例患者治疗有效。作者认为,在患有下肢闭塞性病变的患者中,将瓦扎前列素作为手术干预的补充药物使用是合适的,在这种病理情况与缺血性心脏病同时存在时也是如此。